Influenza epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Incidence===
===Gender===
===Age===
*Influenza viruses cause disease among persons in all age groups.
*Rates of infection are highest among children, but the risks for complications, hospitalizations, and deaths from influenza are higher among persons aged 65 years and older, young children, and persons of any age who have medical conditions that place them at increased risk for complications from influenza.
*During 1990--1999, estimated average rates of influenza-associated pulmonary and circulatory deaths per 100,000 persons were:
:* 0.4-0.6 among persons aged 0-49 years
:* 7.5 among persons aged 50-64 years
:* 98.3 among persons aged 65 years and older.
===Complications===
<!---
===Seasonal variation===
===Seasonal variation===
{{further|[[Flu season]]}}
{{further|[[Flu season]]}}
Line 23: Line 43:


New influenza viruses are constantly being produced by [[mutation]] or by [[reassortment]]. Mutations can cause small changes in the hemagglutinin and neuraminidase [[antigen]]s on the surface of the virus. This is called [[antigenic drift]], which creates an increasing variety of strains over time until one of the variants eventually achieves higher [[fitness (biology)|fitness]], becomes dominant, and rapidly sweeps through the human population &ndash; often causing an epidemic.<ref>{{cite journal | author = | title = Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus | journal = Biol Direct | volume = 1 | issue = 1 | pages = 34 | year = 2006 | id = PMID 17067369}}</ref>  In contrast, when influenza viruses re-assort, they may acquire new antigens — for example by reassortment between avian strains and human strains; this is called antigenic shift.  If a human influenza virus is produced with entirely novel antigens, everybody will be susceptible and the novel influenza will spread uncontrollably, causing a pandemic.<ref>{{cite journal | last = Parrish | first = C | coauthors = Kawaoka Y | title = The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses | journal = Annual Rev Microbiol | volume = 59 | issue = | pages = 553–86 | year = | id = PMID 16153179}}</ref> In contrast to this model of pandemics based on antigenic drift and shift, an alternative approach has been proposed where the periodic pandemics are produced by interactions of a fixed set of viral strains with a human population with a constantly-changing set of immunities to different viral strains.<ref>{{cite journal |author=Recker M, Pybus OG, Nee S, Gupta S |title=The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types |url=http://www.pnas.org/cgi/content/full/104/18/7711 |journal=Proc Natl Acad Sci U S A.  |volume=104 |issue=18 |pages=7711–7716 |year=2007 |pmid=17460037}}</ref>
New influenza viruses are constantly being produced by [[mutation]] or by [[reassortment]]. Mutations can cause small changes in the hemagglutinin and neuraminidase [[antigen]]s on the surface of the virus. This is called [[antigenic drift]], which creates an increasing variety of strains over time until one of the variants eventually achieves higher [[fitness (biology)|fitness]], becomes dominant, and rapidly sweeps through the human population &ndash; often causing an epidemic.<ref>{{cite journal | author = | title = Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus | journal = Biol Direct | volume = 1 | issue = 1 | pages = 34 | year = 2006 | id = PMID 17067369}}</ref>  In contrast, when influenza viruses re-assort, they may acquire new antigens — for example by reassortment between avian strains and human strains; this is called antigenic shift.  If a human influenza virus is produced with entirely novel antigens, everybody will be susceptible and the novel influenza will spread uncontrollably, causing a pandemic.<ref>{{cite journal | last = Parrish | first = C | coauthors = Kawaoka Y | title = The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses | journal = Annual Rev Microbiol | volume = 59 | issue = | pages = 553–86 | year = | id = PMID 16153179}}</ref> In contrast to this model of pandemics based on antigenic drift and shift, an alternative approach has been proposed where the periodic pandemics are produced by interactions of a fixed set of viral strains with a human population with a constantly-changing set of immunities to different viral strains.<ref>{{cite journal |author=Recker M, Pybus OG, Nee S, Gupta S |title=The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types |url=http://www.pnas.org/cgi/content/full/104/18/7711 |journal=Proc Natl Acad Sci U S A.  |volume=104 |issue=18 |pages=7711–7716 |year=2007 |pmid=17460037}}</ref>
--->


==References==
==References==
Line 28: Line 49:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Mature chapter]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Influenza| ]]
[[Category:Influenza| ]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Primary care]]
[[Category:Primary care]]
[[Category:Needs overview]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 13:53, 28 October 2014

Influenza Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Influenza from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Influenza epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Influenza epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Influenza epidemiology and demographics

CDC on Influenza epidemiology and demographics

Influenza epidemiology and demographics in the news

Blogs on Influenza epidemiology and demographics

Directions to Hospitals Treating Influenza

Risk calculators and risk factors for Influenza epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

Incidence

Gender

Age

  • Influenza viruses cause disease among persons in all age groups.
  • Rates of infection are highest among children, but the risks for complications, hospitalizations, and deaths from influenza are higher among persons aged 65 years and older, young children, and persons of any age who have medical conditions that place them at increased risk for complications from influenza.
  • During 1990--1999, estimated average rates of influenza-associated pulmonary and circulatory deaths per 100,000 persons were:
  • 0.4-0.6 among persons aged 0-49 years
  • 7.5 among persons aged 50-64 years
  • 98.3 among persons aged 65 years and older.

Complications

References

Template:WH Template:WS